| |
ski properties for sale in bansko
News and Information Article
NEW YORK, Jan. 4 // -- NGN Capital, a $250 million global
healthcare venture fund, announced today its investment in Small Bone
Innovations, Inc. ("SBI"), which recently completed the largest orthopedics
venture round to date at $42.2 million as recorded by Venture Source.
Funds advised by NGN Capital and 3i co-led the financing, which included
$12 million from each of the two groups. The syndicate also included Anspach
Investments, LLC; Axiom Venture Partners III, L.P.; TGAP Venture Capital Fund,
L.P.; Viscogliosi Brothers, LLC; SBI employees; and a select group of leading
orthopedic surgeons.
Founded in 2004, SBI was the first company to focus purely on arthritis
and trauma in small bones and joints in the upper and lower extremities
(shoulder to fingertip and mid-calf to the toe). The company has a deep
pipeline of implants, fixation and tissue technology products which will
enable it to take advantage of the strong growth in this niche of the
orthopedics market.
Kenneth S. Abramowitz, a Managing General Partner of NGN Capital, will
represent NGN Capital on the SBI board. Abramowitz stated, "We are very
excited to join the board of SBI and look forward to helping guide the
companys expansion in the marketplace."
John R. Costantino, a Managing General Partner of NGN Capital who will
hold an observer seat said, "This investment represents a terrific opportunity
in this rapidly growing segment of the orthopedics market, both in the US and
Europe."
Abramowitz further commented, "We are very pleased to have invested in a
talented and experienced management team which, when combined with the
resources of NGN, will accelerate the companys penetration in the global
marketplace."
Anthony G. Viscogliosi, founder of SBI with Viscogliosi Brothers, LLC in
New York, will serve as Chief Executive Officer. Viscogliosi stated, "We are
very gratified to have completed this financing round with such a reputable
syndicate. The financing proceeds will be used to expand SBIs marketing and
infrastructure. During the next 18 months, the company expects to double its
revenues through new product introductions and small acquisitions." Michael
Simpson is the Chief Operating Officer of SBI.
Goodwin Procter LLPs Boston office acted as lead counsel to the
syndicate.
About NGN Capital
NGN Capital is a global healthcare venture capital investment firm with
offices in New York, Heidelberg, Germany and Greenwich, Connecticut. NGN has
investment capabilities across all the major segments in healthcare, including
pharmaceuticals, biopharmaceuticals, medical devices, diagnostics, and
healthcare services.
More information on NGN can be found at http://www.ngncapital.com
About SBI
Small Bone Innovations, Inc. was founded in 2004 by Viscogliosi Bros, LLC
(VB), the New York based merchant banking firm specializing in the
musculoskeletal / orthopedic sector. VB created SBI as the first company to
focus purely on small bone and joint science. By integrating established
companies and professionals in the field, SBI today offers a broad, clinically
proven portfolio of products and technology to treat trauma and diseases in
small bones and joints.
VBs acquisitions and technology licenses include: Avanta Orthopedics,
Inc. (hand/wrist/elbow arthroplasty and trauma products -- USA); Envision
Manufacturing, Inc. (implant manufacturing -- USA); Actipore(TM) (a unique
porous TiNi alloy developed by Biorthex, Inc. in Canada for use in implants);
Artelon(R) (biologically active and biodegradable technology - Sweden);
Xtremi-T, LLC (resorbable trauma technology -- USA); and Fixano, S.A.S. (broad
line of small bone & joint implants -- France).
For more information on SBI visit: http://www.totalsmallbone.com
| |
|
|
 |
ski properties for sale in bansko |
|
|
|
|
|
|
|
|
|
Locations
